<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CONTEXT: <z:chebi fb="0" ids="37659">Oleanolic acid</z:chebi> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e>), a <z:chebi fb="0" ids="36615">triterpenoid</z:chebi> compound, exists in many plants </plain></SENT>
<SENT sid="1" pm="."><plain>It has numerous bioactivities and has been used to treat <z:hpo ids='HP_0012115'>hepatitis</z:hpo> in China </plain></SENT>
<SENT sid="2" pm="."><plain>However, few studies have reported its effect on the central <z:mp ids='MP_0008912'>nervous</z:mp> system, especially in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>OBJECTIVE: To explore the protective effects of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e> on cerebral ischemic injury for the first time </plain></SENT>
<SENT sid="4" pm="."><plain>MATERIALS AND METHODS: Survival time was tested in mice injured by bilateral common carotid artery ligation (BCCAL) </plain></SENT>
<SENT sid="5" pm="."><plain>Neurological function, <z:mpath ids='MPATH_124'>infarct</z:mpath> area, <z:hpo ids='HP_0002181'>cerebral edema</z:hpo>, <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD), <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (GSH-Px), and malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) were estimated in rats operated by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="6" pm="."><plain>Cell survival, <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase (LDH), SOD, reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH), <z:chebi fb="14" ids="32506">MDA</z:chebi>, <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential (MMP) and succinic dehydrogenase (SDH) were detected in <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi>-injured PC12 cells </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Pre-administration with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e> significantly prolonged survival time in mice at 50 and 25 mg/kg, alleviated neurological function, <z:mpath ids='MPATH_124'>infarct</z:mpath> area and <z:hpo ids='HP_0002181'>cerebral edema</z:hpo>, increased SOD and GSH-Px activities and decreased <z:chebi fb="14" ids="32506">MDA</z:chebi> level in rats at 25 and 12.5 mg/kg </plain></SENT>
<SENT sid="8" pm="."><plain>Pre-treatment with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e> at 10 and 1 μM remarkably improved cell survival, enhanced SOD activity and GSH content, reduced LDH and <z:chebi fb="14" ids="32506">MDA</z:chebi> levels and reversed the lowering of MMP and SDH activity </plain></SENT>
<SENT sid="9" pm="."><plain>DISCUSSION AND CONCLUSION: These results demonstrate that <z:chebi fb="0" ids="37659">oleanolic acid</z:chebi> effectively alleviates cerebral ischemic damage in vivo and oxidative injury in vitro, which may be in part due to the modulation of endogenous <z:chebi fb="11" ids="22586">antioxidants</z:chebi> and the improvement of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="37659">Oleanolic acid</z:chebi> may be a potential medicine for attenuating <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>